IE 11 is not supported. For an optimal experience visit our site on another browser.

EpiPen makers reach $465 million settlement with government


Mylan N.V., makers of the EpiPen emergency allergy treatment, have finalized a $465 million settlement with the federal government after the Department of Justice accused them of overcharging Medicaid. The company stirred public outrage last year when it raised the price of a twin pack of EpiPens to $600 from just $100 in 2008.